Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novocure
MedTech
Novocure's TTFields clear phase 3 pancreatic cancer trial
The wearable therapy improved overall survival in first-line patients with inoperable pancreatic adenocarcinoma, one of the most lethal cancers.
Conor Hale
Dec 2, 2024 11:30am
FDA approves Novocure’s tumor field therapy for metastatic NSCLC
Oct 16, 2024 10:14am
BMS vet answers Foghorn’s call for CBO—Chutes & Ladders
Sep 6, 2024 8:30am
Novocure lays off 200 workers in plan to save $60M
Nov 28, 2023 12:51pm
Novocure's electric fields fail phase 3 ovarian cancer trial
Aug 28, 2023 10:15am
ASCO: Novocure's electric fields extend lung cancer survival
Jun 6, 2023 8:00am
